Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 • 9,382 citations
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
2000 • 3,295 citations
A systematic review of the associations between dose regimens and medication compliance
2001 • 2,366 citations
Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability
1989 • 2,127 citations
Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals
1995 • 1,370 citations
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
2000 • 1,050 citations
Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
1998 • 861 citations
Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection Duration
1998 • 751 citations
Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral Therapy
2000 • 708 citations
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
2002 • 647 citations
Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease
2001 • 566 citations
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
1999 • 548 citations
Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
1997 • 423 citations
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
2001 • 382 citations
Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral Therapy
1999 • 256 citations
Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical Practice
2001 • 220 citations
3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine
2000 • 205 citations
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen
2002 • 166 citations
Adherence to Triple Therapy and Viral Load Response
2000 • 116 citations
Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus Infection
1999 • 80 citations
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)
2001 • 62 citations
Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy
2002 • 42 citations
Clinical Pharmacology and Pharmacokinetics of Amprenavir
2002 • 37 citations
Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy
2000 • 30 citations
Effects of Early Antiretroviral Treatment on HIV-1 RNA in Blood and Lymphoid Tissue: A Randomized Trial of Double Versus Triple Therapy
2000 • 29 citations
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience
1999 • 28 citations